Analyst Ratings for Fulcrum Therapeutics (FULC)
FULC Rating Summary
FULC Price Target Summary
- Highest: $17.00 (H.C. Wainwright)
- Lowest: $4.50 (BofA Securities)
- Average: $11.42
* Over Last 12-Mos
Overall Rating:
BUY
Rating Trend:
Avg. $ Target:
$11.42 (+57.5%)
* Over Last 12-Mos
Rating Score: 6.4 / 10
Percentile Rank: 69%
Avg. $ Target:
$11.42 (+57.5%)
* Over Last 12-Mos
Rating Score: 6.4 / 10
Percentile Rank: 69%
| Date | Firm | Analyst | Type | Rating (Past) |
PT (Past) |
Start $ (End $) |
% Chg. | Details |
|---|---|---|---|---|---|---|---|---|
| 3/13/2024 | RBC Capital | Gregory Renza | New Coverage | Outperform (N/A) |
14.00 (N/A) |
10.91 (7.25) |
-33.55% | Details |
| 9/25/2023 | Goldman Sachs » Updated 1/25/2024 |
Corinne Jenkins | New Coverage | Neutral (N/A) |
6.00 (5.00) |
4.09 (7.25) |
77.26% | Details |
 |
||||||||
|
||||||||
|
||||||||
|
||||||||
|
||||||||
|
||||||||
|
||||||||
|
||||||||
